These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9004111

  • 1. Hypothalamic versus pituitary dysfunction in Down's syndrome as cause of growth retardation.
    Castells S, Beaulieu I, Torrado C, Wisniewski KE, Zarny S, Gelato MC.
    J Intellect Disabil Res; 1996 Dec; 40 ( Pt 6)():509-17. PubMed ID: 9004111
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone deficiency in Down's syndrome children.
    Castells S, Torrado C, Bastian W, Wisniewski KE.
    J Intellect Disabil Res; 1992 Feb; 36 ( Pt 1)():29-43. PubMed ID: 1533556
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of hypothalamic-pituitary function in a combination of tests with four hypothalamic releasing hormones and L-dopa in normal subjects and in patients with hypothalamic and/or pituitary disorders.
    Bando H, Yamasaki R, Saito S.
    Endocrinol Jpn; 1989 Oct; 36(5):705-20. PubMed ID: 2559840
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC, Vestergaard P, Jakobsen PE, Falhof J, Laurberg P.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.
    Beccaria L, Marziani E, Manzoni P, Arvat E, Valetto MR, Gianotti L, Ghigo E, Chiumello G.
    Dement Geriatr Cogn Disord; 1998 Apr; 9(2):78-81. PubMed ID: 9524798
    [Abstract] [Full Text] [Related]

  • 8. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
    Schmitt K, Schober E, Birnbacher R, Frisch H.
    Klin Padiatr; 1996 Apr; 208(1):29-34. PubMed ID: 8851324
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J, Iglesias P, Sastre J, Méndez J, Selgas R, Gómez-Pan A.
    Nephron; 1996 Apr; 74(3):548-54. PubMed ID: 8938679
    [Abstract] [Full Text] [Related]

  • 10. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR, Watson L, Mathias CJ.
    Lancet; 1997 Jun 28; 349(9069):1877-81. PubMed ID: 9217760
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic limitations of spontaneous growth hormone measurements in normally growing prepubertal children.
    Lanes R.
    Am J Dis Child; 1989 Nov 28; 143(11):1284-6. PubMed ID: 2510497
    [Abstract] [Full Text] [Related]

  • 12. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB, Root AW, Shulman DI.
    J Clin Endocrinol Metab; 1986 Oct 28; 63(4):968-73. PubMed ID: 3018032
    [Abstract] [Full Text] [Related]

  • 13. Secretion of growth hormone-releasing hormone in patients with idiopathic pituitary dwarfism and acromegaly.
    Yamasaki R, Saito H, Kameyama K, Hosoi E, Saito S.
    Acta Endocrinol (Copenh); 1988 Mar 28; 117(3):273-81. PubMed ID: 2898191
    [Abstract] [Full Text] [Related]

  • 14. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J, Arce V, Lois N, Tresguerres JA, Lima L.
    J Clin Endocrinol Metab; 1990 Dec 28; 71(6):1581-8. PubMed ID: 1977761
    [Abstract] [Full Text] [Related]

  • 15. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
    Pombo M, Barreiro J, Peñalva A, Peino R, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1995 Nov 28; 80(11):3180-4. PubMed ID: 7593423
    [Abstract] [Full Text] [Related]

  • 16. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases].
    Mitsuhashi S, Yamasaki R, Miyazaki S, Saito H, Saito S.
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug 20; 63(8):934-46. PubMed ID: 3123283
    [Abstract] [Full Text] [Related]

  • 17. The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome.
    Arvat E, Gianotti L, Ragusa L, Valetto MR, Cappa M, Aimaretti G, Ramunni J, Grottoli S, Camanni F, Ghigo E.
    Dementia; 1996 Aug 20; 7(5):288-92. PubMed ID: 8872421
    [Abstract] [Full Text] [Related]

  • 18. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects.
    Hanew K, Utsumi A.
    Eur J Endocrinol; 2002 Feb 20; 146(2):197-202. PubMed ID: 11834428
    [Abstract] [Full Text] [Related]

  • 19. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S, Ling SY, Leidy JW, Blaine K, Holtzman T.
    Alcohol Clin Exp Res; 1997 Aug 20; 21(5):826-39. PubMed ID: 9267532
    [Abstract] [Full Text] [Related]

  • 20. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
    De Gennaro Colonna V, Zoli M, Settembrini BP, Ciceri S, De Marco A, Cella SG, Agnati LF, Muller EE.
    J Pharmacol Exp Ther; 1996 Feb 20; 276(2):795-800. PubMed ID: 8632352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.